Revelation Biosciences In... (REVB)

2.74

0.14 (5.38%)

At close: Apr 02, 2025, 3:49 PM

2.51

-8.39%

After-hours: Apr 02, 2025, 07:12 PM EDT

Revelation Biosciences Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-15.04B	-120.25K	-10.83M	-11.99M	-1.63M	-3.64K
Depreciation & Amortization	27.92M	25.05K	25.05K	16.78K	n/a	n/a
Stock-Based Compensation	168.85M	155.72K	301.12K	470.88K	43.85K	n/a
Other Working Capital	-2.85M	232.47K	-64.93K	625.86K	-80.5K	3.64K
Other Non-Cash Items	-3.48B	-8.33M	14.96K	52.38K	1.5M	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.42M	982.13K	-730.97K	356.22K	-80.5K	3.64K
Operating Cash Flow	-18.32B	-7.29M	-11.22M	-11.09M	-215.07K	n/a
Capital Expenditures	-19.17K	-4	n/a	-131.96K	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-74.04M	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	525.29K	n/a	n/a
Other Investing Acitivies	-19.15M	n/a	n/a	-525.29K	-74.04M	n/a
Investing Cash Flow	-19.17M	n/a	n/a	-131.96K	-74.04M	n/a
Debt Repayment	n/a	n/a	-796.88K	n/a	15K	n/a
Common Stock Repurchased	n/a	-5K	-7.65M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	12.84B	34.00	11.54M	n/a	-65.4M	10K
Financial Cash Flow	12.85B	14.03M	15.2M	8M	74.26M	n/a
Net Cash Flow	-5.49B	6.74M	3.98M	-3.22M	-74.23M	n/a
Free Cash Flow	-18.34B	-7.29M	-11.22M	-11.22M	-215.07K	n/a